Seizures Market to Grow at a CAGR of 4.42% During 2024-2032, Aided by the Rising Prevalence of Seizure Disorders Across the 8 Major Markets

Seizures Market Overview

Seizures are characterized by an uncontrollable burst of electrical activity in the brain, causing changes in movement, behavior, and levels of consciousness of the affected individual. Focal onset and generalized onset seizures are the two major classes of seizures. The rise in the cases of seizure disorders including epilepsy is a significant growth driver for the market. The development of novel anti-seizure medications and the growing adoption of non-pharmacological treatments are poised to fuel the market growth. Further, increased awareness programs and a rise in government initiatives are anticipated to augment the market demand. Additionally, the growth in the number of clinical trials and increased funding for epilepsy research projects are projected to influence the market dynamics in the coming years.

Key Findings

• Recent data suggests that around 70% of individuals  affected by epilepsy can become seizure-free if they take appropriate antiseizure medications. The growing adoption of such drugs to prevent seizure recurrence is driving the market demand.
• In the National Epilepsy Week 2024 , the Epilepsy Research Institute secured the biggest-ever annual investment of EUR 2 million as part of the 2024 Research Awards, which will support 14 new projects in the United Kingdom and internationally, with an aim to advance epilepsy research. Such funding and investments are likely to support market growth in the forecast period.
• The rising interest in alternative and complementary treatments such as deep brain stimulation and the growing focus on the treatment of pediatric epilepsy are significant market trends.

Seizures Market Demand Drivers

According to the World Health Organisation (WHO),  epilepsy is one of the most common neurological diseases and is reported to affect about 50 million individuals globally. It is estimated that 5 million individuals are diagnosed with epilepsy annually. Further, studies suggest that the diagnosis of epilepsy in high-income countries is 49 per 100,000 people every year whereas this figure is around 139 per 100,000 in low- and middle-income countries. The increasing prevalence of epilepsy and other seizure disorders is one of the key factors propelling the market demand.

Seizures Market Segmentation Analysis

Market Segmentation Based on Distribution Channel is Anticipated to Witness Significant Growth

Based on the distribution channel, the market segmentation includes hospital pharmacies, independent pharmacies, online pharmacies, and others. The hospital pharmacies segment holds a high market value and acts as a major distribution channel for antiseizure drugs. They act as a primary point of care for patients experiencing acute or severe forms of seizure disorders. Additionally, online pharmacies are also witnessing rapid growth owing to the increasing internet penetration and the growth in e-commerce platforms.

The market report also offers insights based on drug type, route of administration, end-user, and region.

Seizures Market: Competitive Landscape

• In March 2024 , Sweden-based CombiGene (a developer of novel gene therapies) announced that its novel drug candidate CG01 for drug-resistant focal epilepsy, with existing approved patents in the United States and Russia, was granted a patent in India and Australia.
• In April 2024 , New Jersey-based pharmaceutical company Aquestive Therapeutics, Inc.'s orally-administered rescue product Libervant™ (diazepam) Buccal Film received the U.S. Food and Drug Administration (FDA) approval for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity in pediatric patients between 2 to 5 years of age.
• Other players involved in the market include Pfizer, UCB S.A., Sanofi, Novartis AG, GSK plc, Eisai Co. Ltd., Abbott, Sumitomo Pharmaceutical Co. Ltd., Teva Pharmaceutical Ltd., and Takeda Pharmaceutical Company Limited.

Seizures Market Analysis by Region

United States Holds a Significant Market Share

The market report offers insight into various geographical locations, including the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. The United States is a major market for seizures which can be attributed to the strong pipeline of anti-seizure medications and medical devices in the region. Further, the high incidence of epilepsy and other neurodegenerative conditions also impacts the demand for advanced pharmacological and non-pharmacological therapies. Moreover, the presence of a robust regulatory framework to streamline the market entry of new drugs and devices is projected to bolster the market growth in the region in the forecast period.

Key Offerings of the Report

• The EMR report gives an overview of the market for seizures for the time span of (2017-2023) and (2024-2032).
• The report also offers historical (2017-2023) and forecast (2024-2032) market information for the drug type, route of administration, end-user, distribution channel, and region of the market.
• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which is constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790